Friday | BioSpace
Amylin Pharmaceuticals, Inc. to Present at the Leerink Swann and...
The presentation will be webcast through the "Investors" section of Amylin's corporate website at www.amylin.com , and a recording will be made available following the event.
GlaxoSmithKline: A Good Mix Of Income And Opportunity
There are relatively few drug companies that offer a truly balanced opportunity for investors.
Shlaes: How tax cuts for rich can raise revenue
The Cincinnati Metro New In Town Meetup group will hold a social networking event at Brazenhead Irish Pub on Saturday, Feb.
West Chester business news: Amylin reports wider loss
Diabetes drug maker Amylin Pharmaceuticals Inc., which employs 300 in West Chester, reported a larger fourth-quarter loss after it ended a partnership with Eli Lilly & Co., giving Amylin all the rights to the newly approved, once-weekly diabetes injection Bydureon.
Amylin Pharma (AMLN) Shares Given New $18.00 Price Target by Bank of America (BAC) Analysts
Investment analysts at Bank of America upped their price target on shares of Amylin Pharma to $18.00 in a note issued to investors on Wednesday.
Amylin Pharma (AMLN) Downgraded by TheStreet to "Sell"
Separately, analysts at Jefferies Group reiterated a "buy" rating on shares of Amylin Pharma in a research note to investors on Tuesday.
Analysts Set Amylin, Bankrate, Estee Lauder, Humana at Outperform Stock Rating
Humana Inc. : After Humana reported higher than expected Q4 EPS, Oppenheimer believes that the company's guidance was favorable while its growth outlook remains intact.
Analyst See $38 Price Target for Tesla Motors, as Amylin, Nanometrics, HCA and Kenexa at Outperform
Tesla Motors, Inc. : Barclays believes Tesla's new Model X SUV launch will highlight its innovation capabilities and differentiation.
Stock Trading Alerts Feb. 7th: True Religion, Coinstar, Guess?, Veeco, Amylin
True Religion Apparel Inc. : Benchmark Co. raised its price target for True Religion citing management's strong execution ahead of the company's earnings on February 9. The firm keeps a Buy rating on the stock.
Novo Nordisk Posts Solid 4Q - Analyst Blog
Novo Nordisk reported earnings of $1.51 per American Depository Receipt , in the fourth quarter 2011, much above the Zacks Consensus Estimate of $1.24. Earnings were also ahead of the prior-year earnings of $1.35 per ADR.
The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson &...
Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
Amylin Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Welcome to the Amylin Pharmaceuticals Q4 2011 Earnings Call. [Operator Instructions] This conference is being recorded.
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
"Our strong execution in 2011 has positioned us to enter 2012 with an extraordinary opportunity to maximize shareholder value.
Amylin Pharma (AMLN) Share Price Target Cut to $7.50 by Analysts at Imperial Capital
Analysts at Imperial Capital decreased their price target on shares of Amylin Pharma to $7.50 in a research report issued to clients and investors on Monday.
Stock Analyst Insights: Salesforce.com, National Oilwell, Cognizant Tech, Nabors, Amylin
Salesforce.com : After conducting checks, BMO Capital reports that its sources were upbeat about Salesforce.com's January quarter.
Amylin Pharmaceuticals to produce diabetes drug
The first once-weekly treatment for type 2 diabetes will be made in West Chester Township, according to a recent press release from Amylin Pharmaceuticals .
Amylin Pharmaceuticals continues to soar
Last Friday, the Food and Drug Administration finally approved Bydureon, a once-weekly diabetes shot developed by Amylin Pharmaceuticals and Alkermes PLC .
Highest level of drug-resistant TB found in Europe
The World Health Organization says the highest levels ever of drug-resistant tuberculosis have been found in Russia and Moldova.
New Study for Alkermes' Vivitrol - Analyst Blog
Alkermes plc recently announced the commencement of an open-label pilot study of Vivitrol in adult prisoners who have a history of pre-incarceration of opioid dependence, a chronic brain disorder.
Amylin Pharmaceuticals Shares Popped Again: What You Need to Know
The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Also on Topix